Mark E. Adams
7Patents
3h-index
35Co-inventors
57Inventor score
Filing activity: Jan 28, 1987 → May 14, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7214690B2 | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods | Emerging Cross-Sectional Technologies | 56 | Expired |
| US4792449A | Method for drug administration | Human Necessities | 20 | Expired |
| US6030643A | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | Human Necessities | 4 | Expired |
| US10000468B2 | Pyrazines as modulators of GPR6 | Chemistry; Metallurgy | 1 | Active |
| US10273225B2 | Pyrazines as modulators of GPR6 | Chemistry; Metallurgy | 0 | Active |
| US7442696B2 | Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses | Chemistry; Metallurgy | 0 | Active |
| US7943659B2 | MAPK/ERK kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.